Taken together, these overlapping mechanisms position Lp(a) as both an independent risk factor and a pathophysiological amplifier of LDL-C–driven atherosclerosis and thrombosis, highlighting its therapeutic potential as a dual-target for anti-inflammatory and antithrombotic intervention (47–50) Figure 2. Here, LPA is linked to atherosclerosis.